✦ LIBER ✦

Safety and immunogenicity of a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125) in healthy young adults

✍ Scribed by John J. Treanor; David N. Taylor; Lynda Tussey; Christine Hay; Carrie Nolan; Theresa Fitzgerald; Ge Liu; Uma Kavita; Langzhou Song; Irving Dark; Alan Shaw

Book ID: 116963161
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 182 KB
Volume: 28
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2010.10.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of a recombina

Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults

✍ Christine B. Turley; Richard E. Rupp; Casey Johnson; David N. Taylor; Julie Wolf 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 299 KB

Development of VAX128, a recombinant hem

Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response

✍ David N. Taylor; John J. Treanor; Eric A. Sheldon; Casey Johnson; Scott Umlauf; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 581 KB

Safety and immunogenicity of a recombina

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans

✍ John J. Treanor; Bethanie E. Wilkinson; Feda Masseoud; Jean Hu-Primmer; Rosalyn 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Induction of a potent immune response in

Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125, STF2.HA1 SI)

✍ David N. Taylor; John J. Treanor; Cynthia Strout; Casey Johnson; Theresa Fitzger 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Immunogenicity and safety of a novel lip

Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME-VAC) in young adults

✍ Arie Ben-Yehuda; Aviva Joseph; Evelyne Zeira; Simcha Even-Chen; Igal Louria-Hayo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Abstract Influenza and its complications account for substantial morbidity and mortality among young adults and especially among the elderly. In young adults, immunization provides 70–90% protection, while among the elderly the vaccine may be only 30–40% effective; hence the need for new, more i

Immunogenicity and safety assessment of

Immunogenicity and safety assessment of the Cuban recombinant hepatitis B vaccine in healthy adults

✍ Zurina Cinza Estévez; Arístides Aguilar Betancourt; Verena Muzio González; Nelvi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 156 KB